Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > A question for all
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(618)
•••
Comment by Rumpl3StiltSkinon Feb 09, 2021 2:44pm
264 Views
Post# 32515393

RE:A question for all

RE:A question for all
BlueFranky wrote: To everyone concerned If someone close to you expressed an interest in reading the most compelling pieces of information, pointing toTLT ad a case of when, not if... which links would you provide? Thank you in advance


The best stuff lately is the speculative stuff, and most of that is locked in prior posts here on this Sh Bullboard:

Will RP take up 1433 in their upcoming phase 1 for NSCLS, giving TLT a freebie Phase 1 and large animal interstitial models?

Will U of M and Dr. Combs give us some great small animal data that will lead to a cheap effective Covid 19 treatment and vaccine? This time the Cad govt. paying the bill.

Will Dr. Sherri MaC drag 1433 firmly into other freebie Phase 1s for skin and Breast cancer indications?

Yeah and O' course pointing out what the expectations are for this phase 2 in the comming months.

From there maybe the news releases describing the Dr. Mac 'super compounds' ?

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities